ArticleBMJ oncology2024

Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review.

Hannah Louise Bromley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.